For the experienced in IPR

 

US12157878 Cellretention 1Japan Patent Cellmembra 1 JP7298054South Korean Patent Cellmembra 1 10 2621101US9228579 Cercore1US9677038 Cercore 2US10288060 Cerphragm 1US10508647 Cerphragm 1US11414642 Cellmembra 1US12110484 Cellmembra 2

Please find here some of the patents and applications and owned by Stobbe Group illustrated - all within the pharma world

CerCore1 - "Method and device for industrial biolayer cultivation" - packed-bed bioreactor for expression or proliferation

• EP patent granted - EP2379699
• Germany patent granted - EP2379699
• Switzerland patent granted – EP2379699
• England patent granted - EP2379699
• France patent granted - EP2379699

CerCore1 - "Method and device for industrial biolayer cultivation"

• US patent granted - US 9,228,579

CerCore2 - "Device and method for industrial cultivation of cells"

• US patent granted - US 9,677,038

----------------------------------

CerPhragm 1 - "Electronically controlled diaphragm pump"

• EP patent granted - EP2379889
• Germany patent granted – 60 2009 033 969.9
• Switzerland patent granted – EP2379889
• England patent granted – EP2379889
• France patent granted – EP2379889
• Italy patent granted - EP2379889

CerPhragm 2 - "Electronically controlled diaphragm pump" (including fluid valves)

• US patent granted - US 10,288,060

CerPhragm 3 - "Electronically controlled diaphragm pump" (excluding fluid valves)

• US patent granted – US 10,508,647

----------------------------------

CellMembra - "Disposable Bioprocess System supporting biological activity" (including fluid valves)

• EP pending - 16724365.8
• Canada pending - 2,993,709
• US patent granted #1 - US 11,414,642
• US patent granted #2 - US 12,110,484
• China pending - 2016800571984
• South Korea granted - 10-2621101
• South Korea application pending - 10-2023-7037669
• Japan patent granted #1- 7298054
• Japan divisional / continuation application #2 - 2023-078318

US continuations

• US patent application-3 – US 2023/0042475

----------------------------------

CellRetention - "Disposable Bioprocess System for biological activity" (excluding fluid valves)

• US patent granted #1 - US 12,157,878

US continuations

• US patent application #2 - US 2023/0056468
• US patent application #3 - US 2023/0203426

----------------------------------

SilCon - "Simplified fluid connection and membrane filter" - Hollow-Fibre-Filter cartridge and simplified connections

• PCT application published 2021-04-14 - WO2021069586
• US patent application - US 2022/0347630A1
• EP patent application - 20789080.7

----------------------------------

Rotating SUB – “Bioprocess System extending a biological process“ - continues processing

• PCT application - PCT/EP2024/066212 - 2024-06-12 - not published yet

----------------------------------

Rotating valve – "A No-Dead-Volume-Valve for fluid control"

• DK application - DK/PA 2024/30452 - 2024-08-07 - not published yet